The chemical class known as KIN17 inhibitors represents a group of compounds that specifically target and modulate the activity of the KIN17 protein. KIN17, short for Kinase anchor for XRCC1, is a nuclear protein involved in various cellular processes, particularly in the context of DNA damage response and repair mechanisms. The inhibitors within this chemical class exert their effects by interfering with the normal function of KIN17, thereby influencing downstream cellular pathways associated with DNA repair. KIN17 plays a crucial role in recognizing and binding to damaged DNA, facilitating the recruitment of other repair factors to the site of damage. Inhibitors of KIN17 may disrupt these interactions, impeding the proper orchestration of the cellular response to DNA damage.
KIN17 inhibitors are designed to interact with specific regions of the KIN17 protein, inhibiting its kinase activity or disrupting its binding to other proteins involved in DNA repair. The development of these inhibitors often involves a detailed understanding of the three-dimensional structure of KIN17 and the identification of key binding sites. The rational design of molecules with high affinity for these sites enhances their efficacy as inhibitors. Research in this area aims to elucidate the precise mechanisms through which KIN17 inhibitors influence DNA repair processes. The exploration of KIN17 inhibitors contributes valuable insights into the intricate web of cellular pathways governing DNA damage response.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates DNA, disrupting its structure and impeding the function of proteins like KIN17 involved in DNA processes. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits topoisomerase II, an enzyme needed for DNA unwinding and replication, indirectly affecting KIN17's role in these processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin binds to DNA and causes cross-linking, disrupting the DNA structure and the processes KIN17 is involved in. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil gets incorporated into RNA and DNA, leading to disruptions in their structure and function, affecting KIN17's role. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin binds to the topoisomerase I - DNA complex, preventing DNA unwinding and replication, affecting KIN17's role. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin binds to DNA and causes strand breaks, disrupting the DNA structure and the processes KIN17 is involved in. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, an enzyme involved in the synthesis of nucleotides needed for DNA replication. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Gemcitabine gets incorporated into DNA, causing premature termination of DNA synthesis, affecting KIN17's role. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C cross-links DNA, disrupting its structure and impeding the function of proteins like KIN17 involved in DNA processes. | ||||||
Carboplatin | 41575-94-4 | sc-202093 sc-202093A | 25 mg 100 mg | $48.00 $135.00 | 14 | |
Carboplatin forms covalent bonds with DNA, creating DNA cross-links and disrupting the DNA structure and the processes KIN17 is involved in. | ||||||